Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Bergfeld

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
The British Journal of Dermatology|January 8, 2019
Serum and blister-fluid elevation and decreased epidermal content of high-mobility group box 1 protein in drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysisD F Carr, C-W Wang, T Bellón, et al.
Journal of the American Academy of Dermatology|October 20, 1998
Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study GroupK D Kaufman, E A Olsen, D Whiting, et al.
Journal of the American Academy of Dermatology|October 26, 2000
Lack of efficacy of finasteride in postmenopausal women with androgenetic alopeciaV H Price, J L Roberts, M Hordinsky, et al.
Journal of the American Academy of Dermatology|September 25, 1999
Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair lossJ L Roberts, V Fiedler, J Imperato-McGinley, et al.
The British Journal of Dermatology|June 9, 2021
Guidelines for clinical trials of frontal fibrosing alopecia: consensus recommendations from the International FFA Cooperative Group (IFFACG)E A Olsen, M Harries, A Tosti, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
The British Journal of Dermatology|January 8, 2019
Serum and blister-fluid elevation and decreased epidermal content of high-mobility group box 1 protein in drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysisD F Carr, C-W Wang, T Bellón, et al.
Journal of the American Academy of Dermatology|October 20, 1998
Finasteride in the treatment of men with androgenetic alopecia. Finasteride Male Pattern Hair Loss Study GroupK D Kaufman, E A Olsen, D Whiting, et al.
Journal of the American Academy of Dermatology|October 26, 2000
Lack of efficacy of finasteride in postmenopausal women with androgenetic alopeciaV H Price, J L Roberts, M Hordinsky, et al.
Journal of the American Academy of Dermatology|September 25, 1999
Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair lossJ L Roberts, V Fiedler, J Imperato-McGinley, et al.
The British Journal of Dermatology|June 9, 2021
Guidelines for clinical trials of frontal fibrosing alopecia: consensus recommendations from the International FFA Cooperative Group (IFFACG)E A Olsen, M Harries, A Tosti, et al.
Pageof 3